The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Clavudale 400 mg/100 mg tablets for dogs

400, 100 mg/tablet Tablet

Dechra Regulatory B.V.VPA22622/005/003

Main Information

Trade NameClavudale 400 mg/100 mg tablets for dogs
Active SubstancesAmoxicillin
Clavulanic acid
Strength400, 100 mg/tablet
Dosage FormTablet
Licence HolderDechra Regulatory B.V.
Licence NumberVPA22622/005/003

Group Information

ATC CodeQJ01CR02 amoxicillin and enzyme inhibitor
Therapeutic ClassAntibacterial


Licence Issued15/04/2011
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back